Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-754807 +/- Letrozole in HR+ Breast Cancer
NCT01225172Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2010
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-754807 in breast cancer, sponsored by Bristol Myers Squibb. Started Dec 2010; status: terminated.
02
Drugs
BMS-754807
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01225172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225172.